Aiko Maejima

Chuo, 1040045, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancer.

Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancer.

Journal: Breast cancer research and treatment

Published: January 23, 2026

Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer.

Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer.

Journal: Breast cancer (Tokyo, Japan)

Published: April 19, 2025

The prognostic factors and treatment patterns of the first recurrence of retroperitoneal liposarcoma.

The prognostic factors and treatment patterns of the first recurrence of retroperitoneal liposarcoma.

Journal: International journal of clinical oncology

Published: December 14, 2024

Outcomes of Patients With International Germ Cell Cancer Collaborative Group Good Prognosis Metastatic Seminoma Undergoing De-Escalation Chemotherapy: A Single-Center Retrospective Study.

Outcomes of Patients With International Germ Cell Cancer Collaborative Group Good Prognosis Metastatic Seminoma Undergoing De-Escalation Chemotherapy: A Single-Center Retrospective Study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: December 11, 2024

Treatment and Reasons for Choosing Treatment in Breast Cancer Patients Who Underwent Next-Generation Sequencing Test.

Treatment and Reasons for Choosing Treatment in Breast Cancer Patients Who Underwent Next-Generation Sequencing Test.

Journal: Oncology

Published: October 24, 2024

Efficacy of Eribulin Monotherapy in Patients With Unresectable and/or Metastatic Adenoid Cystic Carcinoma Receiving Platinum-Based Therapy.

Efficacy of Eribulin Monotherapy in Patients With Unresectable and/or Metastatic Adenoid Cystic Carcinoma Receiving Platinum-Based Therapy.

Journal: Head & neck

Published: September 13, 2024

Predicting Trabectedin Efficacy in Soft Tissue Sarcoma: Inflammatory Biomarker Analysis.

Predicting Trabectedin Efficacy in Soft Tissue Sarcoma: Inflammatory Biomarker Analysis.

Journal: Anticancer research

Published: March 01, 2024

Clinical characteristics and survival outcomes of elderly patients with de novo metastatic germ cell tumors.

Clinical characteristics and survival outcomes of elderly patients with de novo metastatic germ cell tumors.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: January 23, 2024

The impact of rare cancer and early-line treatments on the benefit of comprehensive genome profiling-based precision oncology.

The impact of rare cancer and early-line treatments on the benefit of comprehensive genome profiling-based precision oncology.

Journal: ESMO open

Published: July 11, 2023

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer.

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer.

Journal: Frontiers in oncology

Published: February 03, 2023

Impact of relative dose intensity of trabectedin with pegfilgrastim support: a single-centre retrospective study.

Impact of relative dose intensity of trabectedin with pegfilgrastim support: a single-centre retrospective study.

Journal: Journal of chemotherapy (Florence, Italy)

Published: January 12, 2023

Predictive value of peripheral blood markers in soft tissue sarcoma patients treated with eribulin.

Predictive value of peripheral blood markers in soft tissue sarcoma patients treated with eribulin.

Journal: Japanese journal of clinical oncology

Published: November 17, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026